Across TCGA pan-cancer cohorts, SUMO2P8 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SUMO2P8’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where SUMO2P8 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SUMO2P8 is over-expressed in tumor.

LUAD and COAD are the cancer types where SUMO2P8 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SUMO2P8 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.358	.033	2	view →
COAD	All	All	+0.170	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: SUMO2P8 RNA expression & survival · all SUMO2P8 data types